Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1040470/000165495421011091/aehr_10q.htm
April 2022
March 2022
January 2022
January 2022
January 2022
October 2021
October 2021
September 2021
September 2021
July 2021
Aehr
Test Systems
|
MKR
Investor Relations Inc.
|
Ken
Spink
|
Todd Kehrli or Jim
Byers
|
Chief Financial
Officer
|
Analyst/Investor
Contact
|
(510) 623-9400
x309
|
(323)
468-2300
|
|
aehr@mkr-group.com
|
Aehr Test Systems Reports First Quarter Fiscal 2022 Financial
Results
|
|
|
|
|
|
||
September 23, 2021
|
|
|
|
|
|
|
|
Page 2 of 6
|
|
|
|
|
|
|
Aehr Test Systems Reports First Quarter Fiscal 2022 Financial
Results
|
|
|
|
|
|
||
September 23, 2021
|
|
|
|
|
|
|
|
Page 3 of 6
|
|
|
|
|
|
|
Aehr Test Systems Reports First Quarter Fiscal 2022 Financial
Results
|
|
|
|
|
|
||
September 23, 2021
|
|
|
|
|
|
|
|
Page 4 of 6
|
|
|
|
|
|
|
AEHR TEST SYSTEMS AND SUBSIDIARIES
|
||||||||
Condensed Consolidated Statements of Operations
|
||||||||
(in thousands,
except per share data)
|
||||||||
(unaudited)
|
||||||||
|
|
Three Months
Ended
|
||
|
Aug
31,
|
May
31,
|
Aug
31,
|
|
2021
|
2021
|
2020
|
|
|
|
|
Net
sales
|
$5,646
|
$7,638
|
$2,012
|
Cost of
sales
|
3,365
|
4,104
|
1,785
|
Gross
profit
|
2,281
|
3,534
|
227
|
|
|
|
|
Operating
expenses:
|
|
|
|
Selling,
general and administrative
|
1,953
|
1,904
|
1,514
|
Research
and development
|
1,321
|
1,029
|
900
|
Total
operating expenses
|
3,274
|
2,933
|
2,414
|
|
|
|
|
(Loss)
income from operations
|
(993)
|
601
|
(2,187)
|
|
|
|
|
Interest expense,
net
|
(9)
|
(11)
|
(13)
|
Net gain from
dissolution of Aehr Test Systems Japan
|
-
|
-
|
2,186
|
Income from forgiveness
of PPP loan
|
1,698
|
-
|
-
|
Other income (expense),
net
|
23
|
(23)
|
(94)
|
|
|
|
|
|
|
|
|
Income
(loss) before income tax (expense) benefit
|
719
|
567
|
(108)
|
|
|
|
|
Income tax (expense)
benefit
|
(23)
|
-
|
215
|
|
|
|
|
|
|
|
|
Net
income
|
$696
|
$567
|
$107
|
|
|
|
|
Net income per
share
|
|
|
|
Basic
|
$0.03
|
$0.02
|
$0.00
|
Diluted
|
$0.03
|
$0.02
|
$0.00
|
|
|
|
|
Shares used in per
share calculations:
|
|
|
|
Basic
|
23,999
|
23,659
|
23,248
|
Diluted
|
25,356
|
23,916
|
23,455
|
Aehr Test Systems Reports First Quarter Fiscal 2022 Financial
Results
|
|
|
|
|
|
|||
September 23, 2021
|
|
|
|
|
|
|
|
|
Page 5 of 6
|
|
|
|
|
|
|
|
AEHR TEST SYSTEMS AND SUBSIDIARIES
|
|||||||||
Reconciliation of GAAP to Non-GAAP Results
|
|||||||||
(in thousands,
except per share data)
|
|||||||||
(unaudited)
|
|
Three Months
Ended
|
||
|
Aug
31,
|
May
31,
|
Aug
31,
|
|
2021
|
2021
|
2020
|
|
|
|
|
GAAP net
income
|
$696
|
$567
|
$107
|
Stock-based
compensation expense
|
588
|
303
|
270
|
Dissolution of Aehr
Test Systems Japan
|
-
|
-
|
(2,401)
|
Income from forgiveness
of PPP loan
|
(1,698)
|
-
|
-
|
Non-GAAP net (loss)
income
|
$(414)
|
$870
|
$(2,024)
|
|
|
|
|
GAAP net income per
diluted share
|
$0.03
|
$0.02
|
$0.00
|
Non-GAAP net (loss)
income per diluted share
|
$(0.02)
|
$0.04
|
$(0.09)
|
Shares used in GAAP
diluted shares calculation
|
25,356
|
23,916
|
23,455
|
Shares used in non-GAAP
diluted shares calculation
|
23,999
|
23,916
|
23,248
|
Aehr Test Systems Reports First Quarter Fiscal 2022 Financial
Results
|
|
|
||||
September 23, 2021
|
|
|
|
|
||
Page 6 of 6
|
|
|
|
|
|
|
|
|
|
|
|
|
AEHR TEST SYSTEMS AND SUBSIDIARIES
|
||||||
Condensed Consolidated Balance Sheets
|
||||||
(in
thousands)
|
||||||
(unaudited)
|
|
August
31,
|
May
31,
|
|
2021
|
2021
|
|
|
|
ASSETS
|
|
|
|
|
|
Current
assets:
|
|
|
Cash and
cash equivalents
|
$6,530
|
$4,582
|
Accounts
receivable, net
|
4,264
|
5,202
|
Inventories
|
10,146
|
8,849
|
Prepaid
expenses and other
|
759
|
551
|
Total
current assets
|
21,699
|
19,184
|
|
|
|
Property and equipment,
net
|
676
|
677
|
Operating lease
right-of-use assets
|
1,437
|
1,606
|
Other
assets
|
189
|
198
|
Total
assets
|
$24,001
|
$21,665
|
|
|
|
LIABILITIES
AND SHAREHOLDERS' EQUITY
|
|
|
|
|
|
Current
liabilities:
|
|
|
Accounts
payable
|
2,753
|
2,893
|
Accrued
expenses
|
1,978
|
2,163
|
Operating
lease liabilities, short-term
|
750
|
737
|
Customer
deposits and deferred revenue, short-term
|
3,279
|
189
|
Line of
credit
|
-
|
1,400
|
Current
portion of long-term debt
|
-
|
1,679
|
Total
current liabilities
|
8,760
|
9,061
|
|
|
|
Operating lease
liabilities, long-term
|
813
|
1,007
|
Deferred revenue,
long-term
|
150
|
99
|
Other
liabilities
|
46
|
49
|
Total
liabilities
|
9,769
|
10,216
|
|
|
|
Total
shareholders' equity
|
14,232
|
11,449
|
|
|
|
Total
liabilities and shareholders' equity
|
$24,001
|
$21,665
|
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1040470/000165495421011091/aehr_10q.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Aehr Test Systems.
Aehr Test Systems's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:
Rating
Learn More![]()
The increase in gross profit margin was primarily the result of manufacturing efficiencies due to an increase in net sales.
We anticipate that the existing cash balance together with future income from operations, collections of existing accounts receivable, revenue from our existing backlog of products as of this filing date, the sale of inventory on hand, deposits and down payments against significant orders will be adequate to meet our working capital and capital equipment requirement needs over the next 12 months.
Other changes in cash from operations primarily resulted from an increase in customer deposits and deferred revenue of $3.1 million, partially offset by an increase in inventories of $1.3 million.
Gross profit margin increased to 40.4% for the three months ended August 31, 2021 from 11.3% for the three months ended August 31, 2020.
SG&A expenses increased to $2.0 million for the three months ended August 31, 2021 from $1.5 million for the three months ended August 31, 2020, an increase of 29.0%.
The decrease in accounts receivable...Read more
For the three months ended...Read more
The increase in SG&A expenses...Read more
The changes were due to...Read more
Gross profit increased to $2.3...Read more
Other change in cash from...Read more
While the overall environment remains...Read more
On an ongoing basis, we...Read more
Net sales increased to $5.6...Read more
Additionally, if we raise additional...Read more
The increase in net sales...Read more
Net sales of our wafer-level...Read more
Net sales of our TDBI...Read more
R&D expenses increased to $1.3...Read more
Net gain from dissolution of...Read more
Due to the impact of...Read more
Factors that could cause or...Read more
Our future capital requirements will...Read more
The change in other income...Read more
Since inception, we have incurred...Read more
Income tax expense was $23,000...Read more
GAIN FROM FORGIVENESS OF PPP...Read more
NET GAIN FROM DISSOLUTION OF...Read more
The increase in R&D expenses...Read more
The increase in inventory was...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
Aehr Test Systems provided additional information to their SEC Filing as exhibits
Ticker: AEHR
CIK: 1040470
Form Type: 10-Q Quarterly Report
Accession Number: 0001654954-21-011091
Submitted to the SEC: Thu Oct 14 2021 4:01:50 PM EST
Accepted by the SEC: Thu Oct 14 2021
Period: Tuesday, August 31, 2021
Industry: Instruments For Meas And Testing Of Electricity And Elec Signals